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l of ChAbstract Methyldopa, which released in 1960, is one of the most popular blood pressure lowering
drugs. Taking this medicine for high blood pressure, it seems that the effect drug in blood pressure
duct ions convection to alpha-methyl is nor epinephrine. Alpha-methyl nor epinephrine from thus
reducing central blood pressure is. This work reports an investigation of an antihypertensive drug
methyldopa with the combined density functional theory (DFT) and its structure was optimized at
B3LYP, BLYP and MP2(3–21G*,6–31G,6–31G*) levels and the molecular structure in different sol-
vents (SCRF calculation), NMR parameters were calculated using DFT at B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*) basis set. And ﬁnally we calculated natural bond orbital (NBO)
parameters for this structure.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Micro dialysis technique is a useful method for in vivo sam-
pling of neurotransmitters, drugs, and metabolites (Benveniste
and Hu¨ttemeier, 1990). The applicability to the study of drug
metabolism and pharmacokinetic in rats has been demon-
strated in several reports (Chen and Steger, 1993; Elmquist
and Sawchuk, 1997). Methyldopa (MD) exerts its antihyper-
tensive effect through a central mechanism that involves the
biotransformation to methyl norepinephrine (Robertsonl.com (M. Noei).
Saud University.
g by Elsevier
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emistry (2013), http://dx.doi.oret al., 1984; van Zwieten et al., 1984). This drug may inhibit
the aromatic amino acid decarboxylase, an enzyme in the bio-
synthetic pathway of catecholamine’s (Ledoux et al., 1983).
Sino aortic denervations (SAD) performed according to Krie-
ger’s procedure induces a labile hypertension in rats, alteration
in serotonergic and cholinergic pathways and an elevation of
the peripheral sympathetic tone (Nakamura and Nakamura,
1981; Giarcovich-Mart´ınez et al., 1983; Alexander et al.,
1976, 1980). Alexander et al. (1988), reported that the striatal
concentration of dopamine and tyrosine hydroxyls activity of
the nigrostriatal system are decreased after differentiation of
arterial baroreceptor nerves. Moreover, it was found that
3,4dihydroxyphenylaceticacid (DOPAC) and HVA levels in
freely moving SAD rats were lower than in sham operated
(SO) rats. In our laboratory, we have seen altered pharmaco-
logical responses to clonidine and MD in SAD rats (Taira
et al., 1983; Taira and Enero, 1989). Moreover, in a recent
study by using the micro dialysis technique, different kineticing Saud University.
yldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Figure 1 Chemical structures of methyldopa.
Table 3-1 Relative energy (kcal/mol) of the methyldopa
structures in gas phase.
Methyldopa/B3LYP/3–21G*(gas) 000.0000
Methyldopa/B3LYP/6–31G(gas) 2384.0299
Methyldopa/B3LYP/6–31G*(gas) 2581.3749
Methyldopa/BLYP/3–21G*(gas) 2604.7405
Methyldopa/BLYP/6–31G(gas) 2765.666
Methyldopa/BLYP/6–31G*(gas) 5052.5005
Methyldopa/MP2/3–21G*(gas) 5175.2312
Methyldopa/MP2/6–31G(gas) 5199.7764
Methyldopa/MP2/6–31G*(gas) 5335.2635
Table 3-2 Relative energy (kcal/mol) of the methyldopa
structures in H2O phase.
Methyldopa/B3LYP/3–21G*(water) 000.0000
Methyldopa/B3LYP/6–31G(water) 2385.6486
Methyldopa/B3LYP/6–31G*(water) 2579.5178
Methyldopa/BLYP/3–21G*(water) 2591.3477
Methyldopa/BLYP/6–31G(water) 2757.9845
Methyldopa/BLYP/6–31G*(water) 5041.0206
Methyldopa/MP2/3–21G*(water) 5168.3198
Methyldopa/MP2/6–31G(water) 5193.4468
Methyldopa/MP2/6–31G*(water) 5332.1585
Table 3-3 Relative energy (kcal/mol) of the methyldopa
structures in methanol phase.
Methyldopa/ B3LYP/3–21G*(methanol) 000.0000
Methyldopa/B3LYP/6–31G(methanol) 2385.6421
Methyldopa/B3LYP/6–31G*(methanol) 2579.5192
Methyldopa/BLYP/3–21G*(methanol) 2591.3526
Methyldopa/BLYP/6–31G(methanol) 2757.9867
Methyldopa/BLYP/6–31G*(methanol) 5041.0048
Methyldopa/MP2/3–21G*(methanol) 5168.3208
Methyldopa/MP2/6–31G(methanol) 5193.4325
Methyldopa/MP2/6–31G*(methanol) 5332.1428
Table 3-4 Relative energy (kcal/mol) of the methyldopa
structures in ethanol phase.
Methyldopa/ B3LYP/3–21G*(ethanol) 000.0000
Methyldopa/B3LYP/6–31G(ethanol) 2385.6385
Methyldopa/B3LYP/6–31G*(ethanol) 2579.5201
Methyldopa/BLYP/3–21G*(ethanol) 2591.3549
Methyldopa/BLYP/6–31G(ethanol) 2757.9881
Methyldopa/BLYP/6–31G*(ethanol) 5040.9963
Methyldopa/MP2/3–21G*(ethanol) 5168.3214
Methyldopa/MP2/6–31G(ethanol) 5193.4261
Methyldopa/MP2/6–31G*(ethanol) 5332.1343
2 M. Noei et al.proﬁles of MD in dialysates from arterial blood or striatum
were seen in SO and SAD rats (Opezzo et al., 2000). Duncan
et al. (1991) and Mizuchi et al., 1983 have demonstrated that
the regional brain distribution of the drugs and their accumu-
lation may be signiﬁcantly different. Therefore, it is possible
that the sin aortic denervation modiﬁes the pharmacokinetic
proﬁle of MD in different brain structures and this could mod-
ify the pharmacological action of this drug on dopaminergic
neurotransmission. The aim of this work was to study the time
course of MD in brain by using the micro dialysis technique in
order to make a pharmacokinetic approach in chloralose–ure-
thane anesthetized SAD rats. We measured the effect of MD
on the dopaminergic metabolism through its action on DO-
PAC and HVA dialysate levels in SO and SAD rats.
Methyldopa, hydroxy-a-methyl-L-tyrosine, is an antihyper-
tensive agent that primarily acts within the central nervous sys-
tem as an a-adrenergic agonist (Fink et al., 1998). Methyldopa
is taken up by adrenergic neurons,where it is decarboxylated
and hydroxylated to form the false transmitter, a-methylnor-
adrenaline, which is less active than noradrenalin on a-recep-
tors and thus less effective in causing vasoconstriction. In
this paper, we describe a fast, sensitive and speciﬁc liquid
chromatography-tandem mass speciﬁc (LC–MS–MS) method
for the quantization of methyldopa using dopa-phenyl D3 as
an internal standard (I.S). The method was applied to a bio-
equivalence study of two oral formulations of methyldopa
(500 mg tablet, legrand metildopa from Ems industrial
pharmaceutical, Brazil, as test formulation and Aldomet from
prodome Quimica e faemaceutica, Brazil as referencePlease cite this article in press as: Noei, M. et al., Design of methyldopa structure and calculation of its properties by quantum
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.021
Table 3-5 NMR parameters’ value (ppm) of C8-N15 bond,
methyldopa in gas phase at the level of B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C8(gas)] 160.481 794.908
B3LYP/3–21G*[N15(gas)] 223.570 62.524
B3LYP/6–31G[C8(gas)] 133.763 3.0703
B3LYP/6–31G[N15(gas)] 220.953 349.166
B3LYP/6–31G *[C8(gas)] 131.753 219.902
B3LYP/6–31G[N15(gas)] 211.580 736.911
BLYP/3–21G*[C8(gas)] 137.178 469.221
BLYP/3–21G*[N15(gas)] 210.250 940.278
BLYP/6–31G[C8(gas)] 123.511 304.009
BLYP/6–31G[N15(gas)] 208.907 180.371
BLYP/6–31G*[C8(gas)] 122.226 411.053
BLYP/6–31G*[N15(gas)] 200.729 1494.614
Table 3-6 NMR parameters value (ppm) of C8-N15 bond,
methyldopa in H2O phase at the level of B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C8(water)] 145.476 3.275
B3LYP/3–21G*[N15(water)] 221.195 2484.84
B3LYP/6–31G[C8(water)] 132.916 158.158
B3LYP/6–31G[N15(water)] 219.408 2149.067
B3LYP/6–31G *[C8(water)] 130.916 70.712
B3LYP/6–31G[N15(water)] 210.910 3031.373
BLYP/3–21G*[C8(water)] 136.171 277.668
BLYP/3–21G*[N15(water)] 208.432 3489.696
BLYP/6–31G[C8(water)] 122.690 118.858
BLYP/6–31G[N15(water)] 207.526 2764.233
BLYP/6–31G*[C8(water)] 121.371 245.113
BLYP/6–31G*[N15(water)] 200.486 3808.631
Table 3-7 NMR parameters value (ppm) of C8–N15 bond,
methyldopa in methanol phase and different solvent at the level
of B3LYP, BLYP and MP2(3–21G*,6–31G,6–31G*)basis set at
the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C8(methanol)] 145.492 8.667
B3LYP/3–21G*[N15(methane)] 221.299 2416.574
B3LYP/6–31G[C8(methanol)] 132.923 156.816
B3LYP/6–31G[N15(methanol)] 219.398 2096.631
B3LYP/6–31G *[C8(methanol)] 130.941 76.9543
B3LYP/6–31G[N15(methanol)] 211.158 2989.215
BLYP/3–21G*[C8(methanol)] 136.205 282.386
BLYP/3–21G*[N15(methanol)] 208.490 3413.925
BLYP/6–31G[C8(methanol)] 122.706 121.576
BLYP/6–31G[N15(methanol)] 207.675 2724.406
BLYP/6–31G*[C8(methanol)] 121.401 248.215
BLYP/6–31G*[N15(methanol)] 200.398 3716.171
Table 3-8 NMR parameters value (ppm) of C8–N15 bond,
methyldopa in phase ethanol at the level of B3LYP,BLYP and
MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C8(ethanol)] 145.492 8.667
B3LYP/3–21G*[N15(Ethan)] 221.299 2416.574
B3LYP/6–31G[C8(ethanol)] 132.923 156.816
B3LYP/6–31G[N15(methanol)] 219.398 2096.631
B3LYP/6–31G *[C8(methanol)] 130.941 76.9543
B3LYP/6–31G[N15(methanol)] 211.158 2989.215
BLYP/3–21G*[C8(methanol)] 136.205 282.386
BLYP/3–21G*[N15(methanol)] 208.490 3413.925
BLYP/6–31G[C8(methanol)] 122.706 121.576
BLYP/6–31G[N15(methanol)] 207.675 2724.406
BLYP/6–31G*[C8(methanol)] 121.401 248.215
BLYP/6–31G*[N15(methanol)] 200.398 3716.171
Table 3-9 NMR parameters value (ppm) of C9‚O14 bond,
methyldopa in phase gas at the level of B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*)basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C9(gas)] 40.881 5769.462
B3LYP/3–21G*[O14(gas)] 68.066 69696.67
B3LYP/6–31G[C9(gas)] 14.761 3917.943
B3LYP/6–31G[O14(gas)] 112.591 88895.334
B3LYP/6–31G *[C9(gas)] 24.044 4337.621
B3LYP/6–31G[O14(gas)] 51.163 45375.438
BLYP/3–21G*[C9(gas)] 38.582 5472.298
BLYP/3–21G*[O14(gas)] 69.961 60826.177
BLYP/6–31G[C9(gas)] 12.644 3694.721
BLYP/6–31G[O14(gas)] 113.020 79022.324
BLYP/6–31G*[C9(gas)] 20.636 4088.411
BLYP/6–31G*[O14(gas)] 59.845 42303.250
Table 3-10 NMR parameters value (ppm) of (C9‚O14 bond,
methyldopa in phase H2O at the level of B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*)basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C9(water)] 38.522 5189.657
B3LYP/3–21G*[O14(water)] 51.306 63255.245
B3LYP/6–31G[C9(water)] 12.078 3073.262
B3LYP/6–31G[O14(water)] 91.174 56809.141
B3LYP/6–31G *[C9(water)] 22.039 3863.335
B3LYP/6–31G[O14(water)] 33.357 37473.70
BLYP/3–21G*[C9(water)] 36.282 4961.34
BLYP/3–21G*[O14(water)] 54.757 56603.273
BLYP/6–31G[C9(water)] 9.944 2887.423
BLYP/6–31G[O14(water)] 94.087 70399.614
BLYP/6–31G*[C9(water)] 18.468 3635.592
BLYP/6–31G*[O14(water)] 43.303 35822.562
Design of methyldopa structure and calculation of its properties by quantum mechanics 3formulation). Methyldopa (MD) is an antihypertensive that
controls the sympathetic nervous system via a central action
(Oparil, 1982). This medication is typically administered to pa-
tients with heart failures, renal failures, and diabetesPlease cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.or(Universal Pharmaceutical Co. Aldomet Tablets, 2008). Fur-
thermore, it is one of the few antihypertensives indicated in
pregnancy-induced hypertension (Universal Pharmaceutical
Co. Aldomet Tablets, 2008; Ellenbogen et al., 1986). A struc-
tural feature of the drug is an amino acid skeleton with a
catechol group as found in DOPA, an anti-Parkinsonismyldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Table 3-11 NMR parameters value (ppm) of (C9‚O14 bond,
methyldopa in phase methanol at the level of B3LYP, BLYP
and MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C9(methanol)] 38.580 5203.947
B3LYP/3–21G*[O14(methane)] 51.718 63373.81
B3LYP/6–31G[C9(methanol)] 12.137 3039.50
B3LYP/6–31G[O14(methanol 91.725 77567.84
B3LYP/6–31G **[C9(methanol)] 22.030 3862.451
B3LYP/6–31G[O14(methanol 33.776 37620.591
BLYP/3–21G*[C9(methanol)] 36.346 4971.069
BLYP/3–21G*[O14(methanol) 55.237 56658.707
BLYP/6–31G[C9(methanol)] 10.009 2911.753
BLYP/6–31G[O14(methanol)] 94.540 70609.686
BLYP/6–31G*[C9(methanol)] 20.394 3655.533
BLYP/6–31G*[O14(methanol)] 43.732 35994.25
Table 3-12 NMR parameters value (ppm) of (C9‚O14 bond,
methyldopa in phase ethanol at the level of B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C9(ethanol)] 38.622 5212.470
B3LYP/3–21G*[O14(ethanol)] 51.990 63434.814
B3LYP/6–31G[C9(ethanol)] 12.177 3052.207
B3LYP/6–31G[O14(ethanol)] 92.090 77715.956
B3LYP/6–31G *[C9(ethano)] 22.055 3868.328
B3LYP/6–31G*[O14(ethanol)] 34.068 37734.66
BLYP/3–21G*[C9(ethanol)] 36.388 4979.687
BLYP/3–21G*[O14(ethanol)] 55.508 56709.391
BLYP/6–31G[C9(ethanol)] 10.041 2919.044
BLYP/6–31G[O14(ethanol)] 94.862 70674.011
BLYP/6–31G*[C9(ethanol)] 18.554 2887.433
BLYP/6–31G*[O14(ethanol)] 44.025 36079.124
Table 3-13 NMR parameters value (ppm) of (C9‚O14 bond,
methyldopa in phase gas at the level of B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C2(gas)] 70.145 3589.259
B3LYP/3–21G*[O11(gas)] 236.582 7984.781
B3LYP/6–31G[C2(gas)] 52.370 3583.371
B3LYP/6–31G[O11(gas)] 225.693 7875.795
B3LYP/6–31G *[C2(gas)] 51.813 3736.603
B3LYP/6–31G[O11(gas)] 238.367 3478.717
BLYP/3–21G*[C2(gas)] 66.611 2697.573
BLYP/3–21G*[O11(gas)] 214.758 9016.010
BLYP/6–31G[C2(gas)] 48.202 2725.496
BLYP/6–31G[O11(gas)] 205.201 8730.879
BLYP/6–31G*[C2(gas)] 48.021 2959.810
BLYP/6–31G*[O11(gas)] 220.133 4636.024
Table 3-14 NMR parameters value (ppm) of (C9‚O14 bond,
methyldopa in phase H2O at the level of B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C2(water)] 70.349 3301.251
B3LYP/3–21G*[O11(water)] 236.119 6374.46
B3LYP/6–31G[C2(water)] 54.503 2846.083
B3LYP/6–31G[O11(water)] 227.411 4451.23
B3LYP/6–31G *[C2(water)] 52.944 3106.150
B3LYP/6–31G[O11(water)] 240.860 1239.169
BLYP/3–21G*[C2(water)] 67.085 2234.05
BLYP/3–21G*[O11(water)] 214.937 7786.13
BLYP/6–31G[C2water)] 50.628 804.472
BLYP/6–31G[O11(water)] 208.358 5371.73
BLYP/6–31G*[C2(water)] 49.504 2296.166
BLYP/6–31G*[O11(water)] 223.778 2233.298
Table 3-15 NMR parameters value (ppm) of (C9‚O14 bond,
methyldopa in phase methanol at the level of B3LYP, BLYP
and MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C2(methanol)] 70.310 3240.964
B3LYP/3–21G*[O11(methane)] 236.200 6474.698
B3LYP/6–31G[C2(methanol)] 54.422 2867.284
B3LYP/6–31G[O11(methanol)] 227.374 4593.612
B3LYP/6–31G *[C2(methanol)] 52.899 3140.964
B3LYP/6–31G[O11(methanol)] 240.803 1302.27
BLYP/3–21G*[C2(methanol)] 67.044 2259.005
BLYP/3–21G*[O11(methanol)] 215.079 7794.946
BLYP/6–31G[C2(methanol)] 50.534 1951.573
BLYP/6–31G[O11(methanol)] 208.231 5575.375
BLYP/6–31G*[C2(methanol)] 49.431 2308.995
B3LYP/3–21G*O11 methanol)] 223.637 2413.872
Table 3-16 NMR parameters value (ppm) of (C9‚O14 bond,
methyldopa in phase ethanol at the level of B3LYP, BLYP and
MP2(3–21G*,6–31G,6–31G*) basis set at the DFT theory.
Method B3LYP/6–31G* Isotropic(riso) Anisotropy(Dr)
B3LYP/3–21G*[C2(ethanol)] 70.303 3256.578
B3LYP/3–21G*[O11(ethanol)] 236.244 6250.898
B3LYP/6–31G[C2(ethanol)] 54.381 2892.082
B3LYP/6–31G[O11(ethanol)] 227.373 4637.340
B3LYP/6–31G v[C2(ethanol)] 52.877 340.931
B3LYP/6–31G*[O11(ethanol)] 240.763 1345.40
BLYP/3–21G*[C2(ethanol)] 67.038 2268.684
BLYP/3–21G*[O11(ethanol)] 215.110 7811.743
BLYP/6–31G[C2(ethanol)] 50.447 1992.851
BLYP/6–31G[O11(ethanol)] 208.268 5603.258
BLYP/6–31G*[C2(ethanol)] 49.380 52.389
BLYP/6–31G*[O11(ethanol)] 223.595 2439.01
4 M. Noei et al.medication. In fact MD possesses a structure in which an a-
hydrogen found in DOPA is replaced by a methyl group
(Fig. 1). It was reported by Garﬁnkel in 1972 that DOPA is de-
graded by mixing it with banana pulp (Garﬁnkel, 1972). He
performed an investigation whereby the powdered DOPAPlease cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.orwas mixed with banana at room temperature, and changes in
the coloration of the mixture resulted – from a faint pink, fol-
lowed by a bright brown, then a dark brown, then a gray, and,
ﬁnally a liquorice-like black. Currently, there is substantial
proof that indicates that the alteration of color is caused byyldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Table 3-17 Second order perturbation theory analysis of
Fock matrix in NBO basis threshold for printing: B3LYP/3–
21G* method.
Phase Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol)
Gas LP(1)O11 BDv(1)C2–C3 4.60
LP(2)O11 BDv(2)C1–C2 33.11
LP(1)O14 BD*(1)C8–C9 1.79
LP(1)O14 BD*(1)C9–O13 0.76
LP(1)N15 BDv(1)C7–C8 1.99
LP(1)N15 BDv(1)C8–C9 0.61
LP(1)N15 BD*(1)C8–C10 8.19
LP(1)N15 BD*(1)C10–H22 1.02
LP(2)O14 BD*(1)C8–C9 19.38
LP(2)O14 BD*(1)C9–O13 41.99
H2O LP(1)O11 BD
*(1)C2–C3 4.59
LP(2)O11 BD*(2)C1–C2 33.11
LP(1)O14 BD*(1)C8–C9 1.76
LP(1)O14 BD*(1)C9–O13 0.76
LP(2)O14 BD*(1)C8–C9 19.16
LP(2)O14 BD*(1)C9–O13 42.02
LP(1)N15 BD*(1)C7–C8 1.98
LP(1)N15 BD*(1)C8–C9 0.61
LP(1)N15 BD*(1)C8–C10 8.08
LP(1)N15 BD*(1)C10–H22 1.00
CH3OH LP(1)O11 BD
*(1)C2–C3 4.59
LP(2)O11 BD*(2)C1–C2 33.11
LP(1)O14 BD*(1)C8–C9 1.77
LP(1)O14 BD*(1)C9–O13 0.76
LP(2)O14 BD*(1)C8–C9 19.17
LP(2)O14 BD*(1)C9–O13 42.02
LP(1)N15 BD*(1)C7–C8 1.98
LP(1)N15 BD*(1)C8–C9 0.61
LP(1)N15 BD*(1)C8–C10 8.08
LP(1)N15 BD*(1)C10–H22 1.00
CH3CH2OH LP(1)O11 BD
*(1)C2–C3 4.59
LP(2)O11 BD*(2)C1–C2 33.11
LP(1)O14 BD*(1)C8–C9 1.77
LP(1)O14 BD*(1)C9–O13 0.76
LP(2)O14 BD*(1)C8–C9 19.17
LP(2)O14 BD*(1)C9–O13 42.02
LP(1)N15 BD*(1)C7–C8 1.98
LP(1)N15 BD*(1)C8–C9 0.61
LP(1)N15 BD*(1)C8–C10 8.08
LP(1)N15 BD*(1)C10–H22 1.00
Table 3-18 Second order perturbation theory analysis of
Fock matrix in NBO basis threshold for printing: B3LYP/6–
31G method.
Phase Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol)
Gas LP(1)O11 BD*(1)C2–C3 5.94
LP(2)O11 BD*(2)C1–C2 27.64
LP(1)O14 BD*(1)C8–C9 1.05
LP(1)O14 BD*(1)C9–O13 0.97
LP(2)O14 BD*(1)C8–C9 0.62
LP(2)O14 BD*(1)C9–O13 0.54
LP(1)N15 BD*(1)C7–C8 1.69
LP(1)N15 BD*(1)C8–C9 1.15
LP(1)N15 BD*(1)C8–C10 9.8
LP(1)N15 BD*(1)C10–H22 0.99
H2O LP(1)O11 BD
*(1)C2–C3 5.92
LP(2)O11 BD*(2)C1–C2 27.61
LP(1)O14 BD*(1)C8–C9 2.73
LP(1)O14 BD*(1)C9–O13 1.33
LP(2)O14 BD*(1)C8–C9 17.01
LP(2)O14 BD*(1)C9–O13 35.17
LP(1)N15 BD*(1)C7–C8 1.68
LP(1)N15 BD*(1)C8–C9 1.16
LP(1)N15 BD*(1)C8–C10 9.67
LP(1)N15 BD*(1)C10–H22 0.97
CH3OH LP(1)O11 BD
*(1)C2–C3 5.92
LP(2)O11 BD*(2)C1–C2 27.61
LP(1)O14 BD*(1)C8–C9 2.73
LP(1)O14 BD*(1)C9–O13 1.33
LP(2)O14 BD*(1)C8–C9 17.01
LP(2)O14 BD*(1)C9–O13 35.17
LP(1)N15 BD*(1)C7–C8 1.68
LP(1)N15 BD*(1)C8–C9 1.16
LP(1)N15 BD*(1)C8–C10 9.67
LP(1)N15 BD*(1)C10–H22 0.97
CH3CH2OH LP(1)O11 BD
*(1)C2–C3 5.92
LP(2)O11 BD*(2)C1–C2 27.61
LP(1)O14 BD*(1)C8–C9 2.73
LP(1)O14 BD*(1)C9–O13 1.33
LP(2)O14 BD*(1)C8–C9 17.02
LP(2)O14 BD*(1)C9–O13 35.16
LP(1)N15 BDv(1)C7–C8 1.68
LP(1)N15 BD*(1)C8–C9 1.16
LP(1)N15 BD*(1)C8–C10 9.67
LP(1)N15 BD*(1)C10–H22 0.97
Design of methyldopa structure and calculation of its properties by quantum mechanics 5polyphenoloxidase (catechol oxidase; EC 1.10.3.1), an enzyme
related with melanin biosynthesis, and found in banana pulp
(Yang et al., 2000; Sojo et al., 1999, 2000).
2. Computational details
In our current study, extensive quantum mechanical calcula-
tions (Monajjemi and Noei, 2010; Noei et al., 2011; Mollaamin
et al., 2011; Noei et al., 2011) of structure of methyldopa (see
Fig. 1), solvent effects on structure of methyldopa and calcula-
tions of NMR parameters have been Performed on a Pentium-
4 based system using GAUSSIAN 98 program.
At ﬁrst, we have modeled the structure of methyldopa with
Chem. ofﬁce package and then optimized at the DFT level of
theory with 3–21G*,6–31G and 6–31G* basis set. After fullPlease cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.oroptimization of those structures, we have calculated NMR
parameters at the levels of B3LYP, BLYP and MP2(3–
21G,6–31G,6–31G*) theory and theoretically explored the sol-
vent effects (water, methanol, ethanol) on the structure of
methyldopa. All relative energy values and NMR shielding
parameters were calculated supposing gauge-included atomic
orbital (GIAO) method.
This process involves sequential transformation of non-
orthogonal atomic orbital’s (AOs) to those of natural atomic
orbital’s (NAOs), natural hybrid orbital’s (NHOs), and NBOs.
Each of these localized basis sets is complete and describes the
wave functions in the most economic method since electron
density and other properties are described by the minimal
amount of .Filled orbital sin the most rapidly convergent
way. Filled NBOs describe the hypothetical, strictly localized
Lewis structure. The interactions between ﬁlled and antiyldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Table 3-20 Second order perturbation theory analysis of
Fock matrix in NBO basis threshold for printing: BLYP/3–
21G* method.
Phase Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol)
Gas LP(1)O11 BD*(1)C2–C3 3.90
LP(2)O11 BD*(2)C1–C2 0.23
LP(1)O14 BD*(1)C8–C9 1.79
LP(1)O14 BD*(1)C9–O13 0.70
LP(2)O14 BD*(1)C8–C9 17.18
LP(2)O14 BD*(1)C9–O13 37.95
LP(1)N15 BD*(1)C7–C8 1.60
LP(1)N15 BD*(1)C8–C10 6.810
LP(1)N15 BD*(1)C10–H22 0.87
H2O LP(1)O11 BD
*(1)C2–C3 3.89
LP(2)O11 BD*(2)C1–C2 29.1
LP(1)O14 BD*(1)C8–C9 1.76
LP(1)O14 BD*(1)C9–O13 0.70
LP(2)O14 BD*(1)C8–C9 16.88
LP(2)O14 BD*(1)C9–O13 37.99
LP(1)N15 BD*(1)C7–C8 1.59
LP(1)N15 BD*(1)C8–C10 6.72
LP(1)N15 BD*(1)C10–H22 0.85
CH3OH LP(1)O11 BD
*(1)C2–C3 3.90
LP(2)O11 BD*(2)C1–C2 29.06
LP(1)O14 BD*(1)C8–C9 1.77
LP(1)O14 BD*(1)C9–O13 0.70
LP(2)O14 BD*(1)C8–C9 16.96
LP(2)O14 BD*(1)C9–O13 37.97
LP(1)N15 BD*(1)C7–C8 1.59
LP(1)N15 BD*(1)C8–C10 6.74
LP(1)N15 BD*(1)C10–H22 0.86
CH3CH2OH LP(1)O11 BD
*(1)C2–C3 3.90
LP(2)O11 BD*(2)C1–C2 29.06
LP(1)O14 BD*(1)C8–C9 1.77
LP(1)O14 BD*(1)C9–O13 0.7
LP(2)O14 BD*(1)C8–C9 16.97
LP(2)O14 BD*(1)C9–O13 37.97
LP(1)N15 BD*(1)C7–C8 1.59
LP(1)N15 BD*(1)C8–C10 6.47
LP(1)N15 BD*(1)C10–H22 0.86
Table 3-19 Second order perturbation theory analysis of
Fock matrix in NBO basis threshold for printing: B3LYP/6–
31G* method.
Phase Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol)
Gas LP(1)O11 BD*(1)C2–C3 6.52
LP(2)O11 BD*(2)C1–C2 28.65
LP(1)O14 BD*(1)C8–C9 2.57
LP(1)O14 BD*(1)C9–O13 1.44
LP(2)O14 BD*(1)C8–C9 19.53
LP(2)O14 BD*(1)C9–O13 33.98
LP(1)N15 BD*(1)C7–C8 0.97
LP(1)N15 BDv(1)C8–C9 0.93
LP(1)N15 BD*(1)C8–C10 0.42
LP(1)N15 BD*(1)C10–H22 0.92
H2O LP(1)O11 BD
*(1)C2–C3 6.50
LP(2)O11 BD*(2)C1–C2 28.70
LP(1)O14 BD*(1)C8–C9 2.53
LP(1)O14 BD*(1)C9–O13 1.45
LP(2)O14 BD*(1)C8–C9 19.23
LP(2)O14 BD*(1)C9–O13 34.02
LP(1)N15 BD*(1)C7–C8 0.97
LP(1)N15 BD*(1)C8–C9 0.93
LP(1)N15 BD*(1)C8–C10 8.30
LP(1)N15 BD*(1)C10–H22 0.90
CH3OH LP(1)O11 BD
*(1)C2–C3 6.50
LP(2)O11 BD*(2)C1–C2 28.70
LP(1)O14 BD*(1)C8–C9 2.53
LP(1)O14 BD*(1)C9–O13 1.45
LP(2)O14 BD*(1)C8–C9 19.24
LP(2)O14 BD*(1)C9–O13 34.02
LP(1)N15 BD*(1)C7–C8 0.97
LP(1)N15 BD*(1)C8–C9 0.93
LP(1)N15 BD*(1)C8–C10 8.31
LP(1)N15 BD*(1)C10–H22 0.91
CH3CH2OH LP(1)O11 BD
*(1)C2–C3 6.50
LP(2)O11 BD*(2)C1–C2 28.70
LP(1)O14 BD*(1)C8–C9 2.53
LP(1)O14 BD*(1)C9–O13 1.45
LP(2)O14 BD*(1)C8–C9 19.24
LP(2)O14 BD*(1)C9–O13 34.02
LP(1)N15 BD*(1)C7–C8 0.97
LP(1)N15 BD*(1)C8–C9 0.93
LP(1)N15 BD*(1)C8–C10 8.31
LP(1)N15 BD*(1)C10–H22 0.91
6 M. Noei et al.bonding (or Rydberg) orbital’s represent the deviation of the
molecule from the Lewis structure and can be used as the mea-
sure of delocalization. This non covalent bonding-anti bonding
interaction can be quantitatively described in terms of NBO
approach that is expressed by means of the second-order per-
turbation interaction energy (E(2)) Reed and Weinhold, 1983,
1985; Reed et al., 1985; Foster and Weinhold, 1980. This en-
ergy represents the estimate of the off diagonal NBO Fock ma-
trix elements. It can be deduced from the second-order
perturbation approach (Chocholousova et al., 2004).
Eð2Þ ¼ qiFði; jÞ2=ðei  ejÞ ð1Þ
where qi is the donor orbital occupancy, ei, ej are diagonal ele-
ments (orbital energies) and F(i, j) is the off-diagonal NBO
Fock matrix element.Please cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.or3. Result and discussion
In this paper DFT and MP2 method with 3–21G*,6–31G and
6–31G* basis set were employed for investigating the struc-
ture’s optimization and energy minimization of methyldopa,
(Fig. 1) which have been summarized in Tables 3-1–3-4. The
MP2 and DFT energies are of particular interest because they
provide results for interactions appearing in solvent medium
considered in this letter, which are in accord with the biological
behavior of methyldopa. Furthermore, recent papers often
tend to ask about the role of water solvent effect on the stabil-
ity of methyldopa structure. The detailed results of relative en-
ergy values for methyldopa structure in gas, water, CH3OH
and CH3CH2OH solvents optimized at B3LYP, BLYP and
MP2 levels of theory with 3–21G*,6–31G and 6–31G* basis
set are summarized in Tables 3-1–3-4.
Regarding most of the systems studied experimentally are
in solution, the formulation of satisfactory theoretical models
for solvated systems has been the object of continuously
increasing interest, therefore, abinitio calculation of nuclear
magnetic shielding has become an indispensable aid in theyldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Table 3-21 Second order perturbation theory analysis of
Fock matrix in NBO basis threshold for printing: BLYP/6–31G
method.
Phase Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol)
Gas LP(1)O11 BD*(1)C2–C3 5.10
LP(2)O11 BD*(2)C1–C2 24.10
LP(1)O14 BD*(1)C8–C9 2.64
LP(1)O14 BD*(1)C9–O13 1.21
LP(2)O14 BD*(1)C8–C9 15.22
LP(2)O14 BD*(1)C9–O13 31.61
LP(1)N15 BD*(1)C7–C8 1.36
LP(1)N15 BD*(1)C8–C9 0.88
LP(1)N15 BD*(1)C8–C10 8.44
LP(1)N15 BD*(1)C10–H22 0.86
H2O LP(1)O11 BD
*(1)C2–C3 5.08
LP(2)O11 BD*(2)C1–C2 24.16
LP(1)O14 BD*(1)C8–C9 2.60
LP(1)O14 BD*(1)C9–O13 1.20
LP(2)O14 BD*(1)C8–C9 14.99
LP(2)O14 BD*(1)C9–O13 31.65
LP(1)N15 BD*(1)C7–C8 1.35
LP(1)N15 BD*(1)C8–C9 0.89
LP(1)N15 BD*(1)C8–C10 8.32
LP(1)N15 BD*(1)C10–H22 0.84
CH3OH LP(1)O11 BD
*(1)C2–C3 5.08
LP(2)O11 BD*(2)C1–C2 24.16
LP(1)O14 BD*(1)C8–C9 2.60
LP(1)O14 BD*(1)C9–O13 1.20
LP(2)O14 BD*(1)C8–C9 150
LP(2)O14 BD*(1)C9–O13 31.65
LP(1)N15 BD*(1)C7–C8 1.35
LP(1)N15 BD*(1)C8–C9 0.89
LP(1)N15 BD*(1)C8–C10 8.33
LP(1)N15 BD*(1)C10–H22 0.84
CH3CH2OH LP(1)O11 BD
*(1)C2–C3 5.08
LP(2)O11 BD*(2)C1–C2 24.15
LP(1)O14 BD*(1)C8–C9 2.60
LP(1)O14 BD*(1)C9–O13 1.20
LP(2)O14 BD*(1)C8–C9 15.00
LP(2)O14 BD*(1)C9–O13 31.64
LP(1)N15 BD*(1)C7–C8 1.35
LP(1)N15 BD*(1)C8–C9 0.89
LP(1)N15 BD*(1)C8–C10 8.33
LP(1)N15 BD*(1)C10–H22 0.84
Table 3-22 Second order perturbation theory analysis of
Fock matrix in NBO basis threshold for printing: BLYP/6–
31G* method.
Phase Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol)
Gas LP(1)O11 BD*(1)C2–C3 5.65
LP(2)O11 BD*(2)C1–C2 24.81
LP(1)O14 BD*(1)C8–C9 2.46
LP(1)O14 BD*(1)C9–O13 1.35
LP(2)O14 BD*(1)C8–C9 17.17
LP(2)O14 BD*(1)C9–O13 30.01
LP(1)N15 BD*(1)C7–C8 0.76
LP(1)N15 BD*(1)C8–C9 0.71
LP(1)N15 BD*(1)C8–C10 7.16
LP(1)N15 BD*(1)C10–H22 0.79
H2O LP(1)O11 BD
*(1)C2–C3 5.64
LP(2)O11 BD*(2)C1–C2 24.91
LP(1)O14 BD*(1)C8–C9 2.43
LP(1)O14 BD*(1)C9–O13 1.35
LP(2)O14 BD*(1)C8–C9 16.92
LP(2)O14 BD*(1)C9–O13 30.04
LP(1)N15 BD*(1)C7–C8 0.76
LP(1)N15 BD*(1)C8–C9 0.72
LP(1)N15 BD*(1)C8–C10 7.10
LP(1)N15 BD*(1)C10–H22 0.78
CH3OH LP(1)O11 BD
*(1)C2–C3 5.64
LP(2)O11 BD*(2)C1–C2 24.90
LP(1)O14 BD*(1)C8–C9 2.43
LP(1)O14 BD*(1)C9–O13 1.35
LP(2)O14 BD*(1)C8–C9 16.93
LP(2)O14 BD*(1)C9–O13 30.04
LP(1)N15 BD*(1)C7–C8 0.76
LP(1)N15 BD*(1)C8–C9 0.72
LP(1)N15 BD*(1)C8–C10 7.10
LP(1)N15 BD*(1)C10–H22 0.78
CH3CH2OH LP(1)O11 BD
*(1)C2–C3 5.64
LP(2)O11 BD*(2)C1–C2 24.90
LP(1)O14 BD*(1)C8–C9 2.43
LP(1)O14 BD*(1)C9–O13 1.35
LP(2)O14 BD*(1)C8–C9 16.93
LP(2)O14 BD*(1)C9–O13 30.03
LP(1)N15 BD*(1)C7–C8 0.76
LP(1)N15 BD*(1)C8–C9 0.72
LP(1)N15 BD*(1)C8–C10 7.10
LP(1)N15 BD*(1)C10–H22 0.78
Design of methyldopa structure and calculation of its properties by quantum mechanics 7investigation of solvent effects on the structural stability and
accurate theoretical NMR data of compounds (Witanowski
et al., 1990, 1990).
As we know the effect of solvent molecules on methyldopa
plays an important role in the chemical behavior of methyl-
dopa we have already presented the results of our extensive
studies of solvent induced effects on the NMR shielding of
methyldopa. Nuclear magnetic resonance (NMR) is based on
the quantum mechanical property of nuclei (Benas et al.,
2000). The chemical shielding refers to the phenomenon which
is associated with the secondary magnetic ﬁeld created by the
induced motions of the electrons that surround the nuclei when
in the presence of an applied magnetic moment l in a magnetic
ﬁeld, B, is as follows:
E ¼ lð1 rÞB ð2ÞPlease cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.orwhere the shielding riso the differential resonance shift due
to the induced motion of the electrons (Magdalena and Sa-
dlej Joanna, 1998). In general, the electron distribution
around a nucleus in a molecule is more spherically symmet-
ric. Therefore, the size of electron current around the ﬁeld,
and hence the size of the shielding, will depend on the ori-
entation of the molecule within the applied ﬁeld B (Melinda,
2003). For chemical shielding (CS) tensor which describes
how the size of shielding varies with molecular orientation,
we often use the following convention for the three principal
components:
r11  r22  r33 ð3Þ
The three values of the shielding tensor are frequently
expressed as the isotropic value riso and their quantities are
deﬁned as follows Sojo et al., 2000. The anisotropy (Dr)yldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Table 3-23 Second order perturbation theory analysis of
Fock matrix in NBO basis threshold for printing: for gas phase.
Method Donor NBO (i) Acceptor NBO (j) E(2) (kcal/mol)
MP2/3–21G* LP(1)O11 BD*(1)C1–C2 0.51
LP(1)O11 BDv(1)C2–C3 6.05
LP(1)O11 BD*(1)C3–O12 0.52
LP(2)O11 BD*(2)C1–C2 35.91
LP(1)O14 BD*(1)C8–C9 2.31
LP(1)O14 BD*(1)C9–O13 0.93
LP(2)O14 BD*(1)C8–C9 22.22
LP(2)O14 BD*(1)C9–O13 50.98
LP(1)N15 BD*(1)C7–C8 20.05
LP(1)N15 BD*(1)C8–C9 0.82
LP(1)N15 BD*(1)C8–C10 9.60
LP(1)N15 BD*(1)C10–H22 1.15
MP2/6–31G LP(1)O11 BD*(1)C2–C3 7.52
LP(2)O11 BD*(2)C1–C2 29.56
LP(1)O11 BD*(1)C8–C9 3.72
LP(1)O11 BD*(1)C9–O13 1.56
LP(2)O14 BD*(1)C8–C9 18.89
LP(2)O14 BD*(1)C9–O13 42.47
LP(1)N15 BD*(1)C7–C8 1.55
LP(1)N15 BD*(1)C8–C9 1.56
LP(1)N15 BD*(1)C8–C10 11.51
LP(1)N15 BD*(1)C10–H22 1.08
MP2–6-31G* LP(1)O11 BD*(1)C2–C3 8.4
LP(2)O11 BD*(2)C1–C2 33.74
LP(1)O11 BD*(1)C8–C9 3.40
LP(1)O11 BD*(1)C9–O13 1.76
LP(2)O14 BD*(1)C8–C9 22.34
LP(2)O14 BD*(1)C9–O13 44.66
LP(1)N15 BD*(1)C7–C8 1.20
LP(1)N15 BD*(1)C8–C9 1.24
LP(1)N15 BD*(1)C8–C10 10.80
LP(1)N15 BD*(1)C10–H22 1.10
8 M. Noei et al.(1) The isotropic value r iso
r ¼ 1=3ðr þ r þ r Þ ð4Þiso 11 22 33Table 3-24 Occupancy and energy (kcal/mol) and hybrid for r (C8
Method Bond H
B3LYP/3–21G*C8-N15(gas) BD(1) C
N
B3LYP/6–31G C8–N15(gas) BD(1) C
N
B3LYP/6–31G* C8–N15(gas) BD(1) C
N
BLYP/3–21G* C8–N15(gas) BD(1) C
N
BLYP/6–31G C8–N15(gas) BD(1) C
N
BLYP/6–31G* C8–N15(gas) BD(1) C
N
MP2/3–21G* C8–N15(gas) BD(1) C
N
MP2/6–31G C8–N15(gas) BD(1) C
N
MP2/6–31G* C8–N15(gas) BD(1) C
N
Please cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.or(1) The anisotropy shielding Dr
Dr ¼ r ðr þ r Þ ð5Þ331=2 11 22
Instead of deriving (rDind) from the difference of the PCM-
optimized in vacuum, it can be obtained from the shielding cal-
culated in vacuum for a molecule that is geometry –optimized
in solution (Monajjemi et al., 2007), thus:
Drind ¼ rvacðRsolÞ  rvacðRrefÞ ð6Þ
where rvac (Rsol) is the value of nuclear shielding in vacuum
but with the solute geometry optimized in solution rvac(Rref)
is the corresponding parameter for calculation with reference
solvent. in this case, we may suppose that optimization of sol-
ute molecule in solvent and then performing shielding calcula-
tion is similar to shielding calculations in the isolated system
(Lynden, 1997).
Self –consistent reaction ﬁeld (SCRF) method is based on a
continuum model with uniform dielectric constant (e). The
simplest SCRF model is the Onsager reaction ﬁeld model. In
this method, the solute occupies a ﬁxed spherical cavity of ra-
dius a within the solvent ﬁeld. A dipole in the molecule will in-
duce a dipole in the medium, and the electric ﬁeld applied by
the solvent dipole will in turn interact with the molecular di-
pole leading to net stabilization. The Gauge Including Atomic
Orbital (GIAO) approach was used. The abinitio GIAO calcu-
lations of NMR chemical shielding tensors were calculated
with the GAUSSIAN 98 W program.
The isotropic chemical shielding (riso) and anisotropy
shielding (Dr) for C8-N15,C9‚O14 and C2–O11 atoms have
been summarized in Tables 3-5–3-16. C8-N15, C9‚O14 and
C2–O11 atoms are very important in this structure, because
these atoms are agent bonding methyldopa.
In the NBO analysis, in order to compute the span of the
valence space, each valence bonding NBO (rAB), must in turn,
be paired with a corresponding valence anti bonding NBO
(r*AB): Namely, the Lewis r-type (donor) NBO are comple-
mented by the non-Lewis r*-type (acceptor) NBO that are for-
mally empty in an idealized Lewis structure picture. Readily,
the general transformation to NBO leads to orbital’s that are–N15) atoms from methyldopa structure in gas phase.
ybrid Occupancy Energy
8 = Sp3.63 1.98257 0.70021
15 = sp2.24
8 = sp3.34 1.98357 0.71848
15 = sp1.97
8 = sp3.34 1.98389 0.70489
15 = sp2.17
8 = sp3.65 1.98158 0.61717
15 = sp2.38
8 = sp3.35 1.98331 0.63765
15 = sp2.03
8 = sp3.36 1.98339 0.62278
15 = sp2.26
8 = sp3.70 1.98383 0.90423
15 = sp2.36
8 = sp3.42 1.98407 0.92945
15 = sp2.09
8 = sp3.37 1.98532 -0.93258
15 = sp2.17
yldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Table 3-25 Occupancy and energy (kcal/mol) and hybrid for r (C8–N15) atoms from methyldopa structure in H2O phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C8–N15(water) BD(1) C8 = Sp3.64 1.98251 0.70176
N15 = sp2.23
B3LYP/6–31G C8–N15(water) BD(1) C8 = sp3.34 1.98351 0.72048
N15 = sp1.96
B3LYP/6–31G* C8–N15(water) BD(1) C8 = sp3.34 1.98382 0.70787
N15 = sp2.17
BLYP/3–21G* C8–N15(water) BD(1) C8 = sp3.65 1.98143 0.61935
N15 = sp2.37
BLYP/6–31G C8–N15(water) BD(1) C2 = sp3.36 1.98323 0.64037
O11 = sp2.02
BLYP/6–31G* C8–N15(water) BD(1) C2 = sp3.36 1.98331 0.62528
O11 = sp2.26
MP2/3–21G* C8–N15(water) BD(1) C2 = sp3.72 1.95510 –
O11 = sp2.36
MP2/6–31G C8–N15(water) BD(1) C2 = sp3.43 1.95489 –
O11 = sp2.07
MP2/6–31G* C8–N15(water) BD(1) C2 = sp3.38 1.94810 –
O11 = sp2.19
Table 3-26 Occupancy and energy (kcal/mol) and hybrid for r (C8–N15) atoms from methyldopa structure in methanol phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C8-N15(methanol) BD(1) C8 = Sp3.64 1.98251 0.70170
N15 = sp2.23
B3LYP/6–31G C8–N15(methanol) BD(1) C8 = sp3.34 1.98351 0.72041
N15 = sp1.96
B3LYP/6–31G* C8–N15(methanol) BD(1) C8 = sp3.34 1.98382 0.70775
N15 = sp2.17
BLYP/3–21G* C8–N15(methanol) BD(1) C8 = sp3.65 1.98147 0.61866
N15 = sp2.38
BLYP/6–31G C8–N15(methanol) BD(1) C2 = sp3.36 1.98323 0.64028
O11 = sp2.02
BLYP/6–31G* C8–N15(methanol) BD(1) C2 = sp3.36 1.98331 0.62518
O11 = sp2.26
MP2/3–21G* C8–N15(methanol) BD(1) C2 = sp3.71 1.95510 –
O11 = sp2.37
MP2/6–31G C8–N15(methanol) BD(1) C2 = sp3.43 1.95489 –
O11 = sp2.07
MP2/6–31G* C8–N15(methanol) BD(1) C2 = sp3.38 1.94810 –
O11 = sp2.19
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NBO of the natural Lewis structure is well adapted to describe
covalency effects in molecules. Since the non-covalent delocal-
ization effects are associated with rﬁ r* interactions between
ﬁlled (donor) and unﬁlled (acceptor) orbital’s, it is natural to
describe them as being of donor–acceptor, charge transfer,
or generalized ‘‘Lewis base-Lewis acid’’ type. The anti bonds
represent unused valence-shell capacity and spanning portions
of the atomic valence space that are formally unsaturated by
covalent bond formation. Weak occupancies of the valence
anti bonds signal irreducible departures from an idealized
localized Lewis picture, i.e. true ‘‘delocalization effects’’. As
a result, in the NBO analysis, the donor–acceptor (bond–anti
bond) interactions are taken into consideration by examining
all possible interactions between ‘ﬁlled’ (donor) Lewis-typePlease cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.orNBO and ‘empty’ (acceptor) non-Lewis NBO and then esti-
mating their energies by second-order perturbation theory.
These interactions (or energetic stabilizations) are referred to
as ‘delocalization’ corrections to the zeroth-order natural Le-
wis structure. The most important interaction between ‘‘ﬁlled’’
(donor) Lewis-type NBO and ‘‘empty’’ (acceptor) non-Lewis is
reported in Tables 3-17–3-23 the level of B3LYP, BLYP and
MP2(3–21G,6–31G,6–31G*) basis set at the DFT theory, we
observed between the LP(1) N15 and r*(1) of C7–C8 of meth-
yldopa LP(1) O11 and r*(1) of C2–C3 methyldopa and ﬁnally
we reported the energy of methyldopa in Tables 3-17–3-23 by
same level.
Tables 3-24–3-35 show calculated natural orbital occu-
pancy (number of electron, or ‘‘natural population’’ of the
orbital). It is noted that for rC8–N15 bond orbital, decreasedyldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Table 3-27 Occupancy and energy (kcal/mol) and hybrid for r (C8–-N15) atoms from methyldopa structure in ethanol phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C8–N15(ethanol) BD(1) C8 = Sp3.64 1.98251 0.70167
N15 = sp2.23
B3LYP/6–31G C8–N15(ethanol) BD(1) C8 = sp3.34 1.98351 0.72037
N15 = sp1.96
B3LYP/6–31G* C8–N15(ethanol) BD(1) C8 = sp3.34 1.98382 0.70769
N15 = sp2.17
BLYP/3–21G* C8–N15(ethanol) BD(1) C8 = sp3.65 1.98147 0.61863
N15 = sp2.38
BLYP/6–31G C8–N15(ethanol) BD(1) C2 = sp3.36 1.98323 0.64023
O11 = sp2.02
BLYP/6–31G* C8–N15(ethanol) BD(1) C2 = sp3.36 1.98331 0.62513
O11 = sp2.26
MP2/3–21G* C8–N15(ethanol) BD(1) C2 = sp3.72 1.95510 –
O11 = sp2.36
MP2/6–31G C8–N15(ethanol) BD(1) C2 = sp3.44 1.95489 –
O11 = sp2.07
MP2/6–31G* C8–N15(ethanol) BD(1) C2 = sp3.38 1.94810 –
O11 = sp2.19
Table 3-28 Occupancy and energy (kcal/mol) and hybrid for r (C9‚O14) atoms from methyldopa structure in gas phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C9 = O14(gas) BD(2) C9 = Sp99.99 1.99170 0.38481
O14 = sp99.99
B3LYP/6–31G C9‚O14(gas) BD(2) C9 = Sp99.99 1.99248 0.39209
O14 = Sp99.99
B3LYP/6–31G* C9‚O14(gas) BD(2) C9 = Sp99.99 1.99267 0.38507
O14 = Sp99.99
BLYP/3–21G* C9‚O14 (gas) BD(2) C9 = Sp99.99 1.99116 0.32753
O14 = Sp99.99
BLYP/6–31G C9‚O14 (gas) BD(2) C9 = Sp99.99 1.99210 0.33554
O14 = Sp99.99
BLYP/6–31G* C9‚O14 (gas) BD(2) C9 = Sp99.99 1.99219 0.32806
O14 = Sp99.99
MP2/3–21G* C9‚O14 (gas) BD(2) C9 = Sp99.99 1.99314 0.52934
O14 = Sp99.99
MP2/6–31G C9‚O14 (gas) BD(2) C9 = Sp99.99 1.99348 0.53287
O14 = Sp99.99
MP2/6–31G* C9‚O14 (gas) BD(2) C9 = Sp99.99 1.99392 0.53459
O14 = Sp99.99
Table 3-29 Occupancy and energy (kcal/mol) and hybrid for r (C9‚O14) atoms from methyldopa structure in H20 phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C9‚O14(water) BD(2) C9 = Sp99.99 1.99188 0.39004
O14 = sp99.99
B3LYP/6–31G C9‚O14(water) BD(2) C9 = Sp99.99 1.99268 0.39844
O14 = Sp99.99
B3LYP/6–31G* C9‚O14(water) BD(2) C9 = Sp99.99 1.99292 0.39357
O14 = Sp99.99
BLYP/3–21G* C9‚O14 (water) BD(2) C9 = Sp99.99 1.99145 0.33508
O14 = Sp99.99
BLYP/6–31G C9‚O14 (water) BD(2) C9 = Sp99.99 1.99236 0.34312
O14 = Sp99.99
BLYP/6–31G* C9‚O14 (water) BD(2) C9 = Sp99.99 1.99244 0.33550
O14 = Sp99.99
MP2/3–21G* C9‚O14 (water) BD(2) C9 = SP1.00 1.94394 –
O14 = SP1.00
MP2/6–31G C9‚O14 (water) BD(2) C9 = SP1.00 1.94101 –
O14 = SP1.00
MP2/6–31G* C9‚O14 (water) BD(2) C9 = SP1.00 1.94059 –
O14 = SP1.00
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Table 3-30 Occupancy and energy (kcal/mol) and hybrid for r (C0‚O14) atoms from methyldopa structure in methanol phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C9‚O14(methanol) BD(2) C9 = Sp99.99 1.99268 0.39822
O14 = sp99.99
B3LYP/6–31G C9‚O14(methanol) BD(2) C9 = Sp99.99 1.99039 0.39556
O14 = Sp99.99
B3LYP/6–31G* C9‚O14(methanol) BD(2) C9 = Sp99.99 1.99291 0.39325
O14 = Sp99.99
BLYP/3–21G* C9‚O14 (methanol) BD(2) C9 = Sp99.99 1.99137 0.33295
O14 = Sp99.99
BLYP/6–31G C9‚O14 (methanol) BD(2) C9 = Sp99.99 1.99235 0.34284
O14 = Sp99.99
BLYP/6–31G* C9‚O14 (methanol) BD(2) C9 = Sp99.99 1.99423 0.33524
O14 = Sp99.99
MP2/3–21G* C9‚O14 (methanol) BD(2) C9 = SP1.00 1.94391 –
O14 = SP1.00
MP2/6–31G C9‚O14 (methanol) BD(2) C9 = SP1.00 1.94100 –
O14 = SP1.00
MP2/6–31G* C9‚O14 (methanol) BD(2) C9 = SP1.00 1.94057 –
O14 = SP1.00
Table 3-31 Occupancy and energy (kcal/mol) and hybrid for r (C9‚O14) atoms from methyldopa structure in ethanol phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C9‚O14(ethanol) BD(2) C9 = Sp99.99 1.99268 0.39822
O14 = sp99.99
B3LYP/6–31G C9‚O14(ethanol) BD(2) C9 = Sp99.99 1.99039 0.39556
O14 = Sp99.99
B3LYP/6–31G* C9‚O14(ethanol) BD(2) C9 = Sp99.99 1.99291 0.39325
O14 = Sp99.99
BLYP/3–21G* C9‚O14 (ethanol) BD(2) C9 = Sp99.99 1.99137 0.33295
O14 = Sp99.99
BLYP/6–31G C9‚O14 (ethanol) BD(2) C9 = Sp99.99 1.99235 0.34284
O14 = Sp99.99
BLYP/6–31G* C9‚O14 (methanol) BD(2) C9 = Sp99.99 1.99423 0.33524
O14 = Sp99.99
MP2/3–21G* C9‚O14 (methanol) BD(2) C9 = SP1.00 1.94391 –
O14 = SP1.00
MP2/6–31G C9‚O14 (methanol) BD(2) C9 = SP1.00 1.94100 –
O14 = SP1.00
MP2/6–31G* C9‚O14 (methanol) BD(2) C9 = SP1.00 1.94057 –
O14 = SP1.00
Table 3-32 Occupancy and energy (kcal/mol) and hybrid for r (C2–O11) atoms from methyldopa structure in gas phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C2–O11(gas) BD(1) C2 = Sp3.11 1.99299 0.88826
O11 = sp2.22
B3LYP/6–31G C2–O11 (gas) BD(1) C2 = sp13.06 1.99330 0.88785
O11 = sp2.09
B3LYP/6–31G C2–O11 (gas) BD(1) C2 = sp2.96 1.99401 0.89468
O11 = sp1.96
BLYP/3–21G* C2–O11 (gas) BD(1) C2 = sp3.12 1.90250 0.79071
O11 = sp2.42
BLYP/6–31G C2–O11 (gas) BD(1) C2 = sp3.10 1.99335 0.79082
O11 = sp2.25
BLYP/6–31G* C2–O11 (gas) BD(1) C2 = sp2.99 1.99373 0.79718
O11 = sp2.09
MP2/3–21G* C2–O11 (gas) BD(1) C2 = sp3.04 1.99402 1.11491
O11 = sp2.25
MP2/6–31G C2–O11 (gas) BD(1) C2 = sp3.01 1.99397 1.11360
O11 = sp2.16
MP2/6–31G* C2–O11gas) BD(1) C2 = sp2.92 1.99486 1.15333
O11 = sp1.92
Design of methyldopa structure and calculation of its properties by quantum mechanics 11
Please cite this article in press as: Noei, M. et al., Design of methyldopa structure and calculation of its properties by quantum
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.021
Table 3-33 Occupancy and energy (kcal/mol) and hybrid for r (C2–O11) atoms from methyldopa structure in H2O phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C2–O11(water) BD(1) C2 = Sp3.11 1.99305 0.88670
O11 = sp2.21
B3LYP/6–31G C2–O11 (water) BD(1) C2 = sp3.07 1.99337 0.88614
O11 = sp2.08
B3LYP/6–31G C2–O11 water) BD(1) C2 = sp2.97 1.99406 0.89148
O11 = sp1.96
BLYP/3–21G* C2–O11 (water) BD(1) C2 = sp3.13 1.99256 0.78792
O11 = sp2.41
BLYP/6–31G C2–O11 (water) BD(1) C2 = sp3.10 1.99312 0.78818
O11 = sp2.24
BLYP/6–31G* C2–O11 (water) BD(1) C2 = sp2.99 1.99377 0.79407
O11 = sp2.08
MP2/3–21G* C2–O11 (water) BD(1) C2 = sp3.07 1.96698 –
O11 = sp2.38
MP2/6–31G C2–O11 (water) BD(1) C2 = sp3.03 1.96526 –
O11 = sp2.28
MP2/6–31G* C2–O11 (water) BD(1) C2 = sp2.93 1.96210 –
O11 = sp2.06
Table 3-34 Occupancy and energy (kcal/mol) and hybrid for r (C2–O11) atoms from methyldopa structure in methanol phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C2–O11(methanol) BD(1) C2 = Sp3.11 1.99305 0.88676
O11 = sp2.21
B3LYP/6–31G C2–O11 (methanol) BD(1) C2 = sp3.07 1.99336 0.88621
O11 = sp2.08
B3LYP/6–31G C2–O11 methanol) BD(1) C2 = sp2.97 1.99406 0.89161
O11 = sp1.96
BLYP/3–21G* C2–O11 (methanol) BD(1) C2 = sp3.13 1.99255 0.78880
O11 = sp2.41
BLYP/6–31G C2–O11 (methanol) BD(1) C2 = sp3.10 1.99312 0.78829
O11 = sp2.24
BLYP/6–31G* C2–O11 (methanol) BD(1) C2 = sp2.99 1.99377 0.79419
O11 = sp2.08
MP2/3–21G* C2–O11 (methanol) BD(1) C2 = sp3.06 1.96697 –
O11 = sp2.39
MP2/6–31G C2–O11 (methanol) BD(1) C2 = sp3.04 1.96526 –
O11 = sp2.26
MP2/6–31G* C2–O11 (methanol) BD(1) C2 = sp2.92 1.96210 –
O11 = sp2.06
Table 3-35 Occupancy and energy (kcal/mol) and hybrid for r (C2–O11) atoms from methyldopa structure in ethanol phase.
Method Bond Hybrid Occupancy Energy
B3LYP/3–21G*C2-O11(ethanol) BD(1) C2 = Sp3.11 1.99304 0.88679
O11 = sp1.89
B3LYP/6–31G C2–O11 (ethanol) BD(1) C2 = sp3.07 1.99336 0.88625
O11 = sp2.08
B3LYP/6–31G C2–O11 (ethanol) BD(1) C2 = sp2.97 1.99406 0.89169
O11 = sp1.96
BLYP/3–21G* C2–O11 (ethanol) BD(1) C2 = sp3.12 1.99255 0.78884
O11 = sp2.41
BLYP/6–31G C2–O11 (ethanol) BD(1) C2 = sp3.10 1.99312 0.78835
O11 = sp2.24
BLYP/6–31G* C2–O11 (ethanol) BD(1) C2 = sp2.99 1.99377 0.79426
O11 = sp2.08
MP2/3–21G* C2–O11 (ethanol) BD(1) C2 = sp3.07 1.96697 –
O11 = sp2.38
MP2/6–31G C2–O11 (ethanol) BD(1) C2 = sp3.04 1.96526 –
O11 = sp2.26
MP2/6–31G* C2–O11 (ethanol) BD(1) C2 = sp2.92 1.96209 –
O11 = sp2.06
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Table 3-39 Thermo chemistry values for methyldopa in ethanol phase.
Method EZPE Etot Hcorr Gcorr CV(tot) Stot Qtot V = 0
B3LYP/3–21G* 141.158 150.374 150.966 114.947 0.056 0.120 0.163D+ 20
B3LYP/6–31G 141.737 151.004 151.596 115.344 0.057 0.121 0.223D+ 20
B3LYP/6–31G* 141.819 151.174 151.767 115.221 0.057 0.122 0.296D+ 20
BLYP/3–21G* 135.716 145.260 145.852 109.132 0.058 0.123 0.262D+ 20
BLYP/6–31G 136.176 145.786 146.378 109.282 0.059 0.124 0.461D+ 20
BLYP/6–31G* 136.448 146.106 146.698 109.495 0.059 0.124 0.579D+ 20
Table 3-36 Thermo chemistry values for methyldopa in gas phase.
Method EZPE Etot Hcorr Gcorr CV(tot) Stot Qtot V = 0
B3LYP/3–21G* 141.155 150.373 150.965 114.942 0.056 0.120 0.164D+ 20
B3LYP/6–31G 141.734 151.002 151.594 115.336 0.057 0.121 0.225D+ 20
B3LYP/6–31G* 141.815 151.171 151.763 115.244 0.057 0.122 0.300D+ 20
BLYP/3–21G* 135.677 145.224 145.817 109.081 0.058 0.123 0.267D+ 20
BLYP/6–31G 136.118 145.736 146.328 109.198 0.059 0.124 0.487D+ 20
BLYP/6–31G* 136.403 146.066 146.658 109.438 0.059 0.124 0.591D+ 20
Table 3-37 Thermo chemistry values for methyldopa in H2O phase.
Method EZPE Etot Hcorr Gcorr Cv(tot) Stot Qtot V = 0
B3LYP/3–21G* 141.191 150.400 150.992 115.014 0.056 0.120 0.147D+ 20
B3LYP/6–31G 141.769 151.031 151.623 115.439 0.057 0.121 0.192D+ 20
B3LYP/6–31G* 141.869 151.212 151.805 115.399 0.057 0.122 0.253D+ 20
BLYP/3–21G* 136.269 145.776 146.368 109.791 0.058 0.122 0.223D+ 20
BLYP/6–31G 136.868 146.426 147.018 110.179 0.059 0.123 0.312D+ 20
BLYP/6–31G* 137.035 146.657 147.250 110.213 0.058 0.124 0.463D+ 20
Table 3-38 Thermo chemistry values for methyldopa in ethanol phase.
Method EZPE Etot Hcorr Gcorr CV(tot) Stot Qtot V = 0
B3LYP/3–21G* 141.157 150.374 150.966 114.945 0.056 0.120 0.163D+ 20
B3LYP/6–31G 141.736 151.003 151.595 115.341 0.057 0.121 0.224D+ 20
B3LYP/6–31G* 141.817 151.173 151.765 115.251 0.057 0.122 0.297D+ 20
BLYP/3–21G* 140.228 148.790 149.382 115.617 0.0552 0.113 0.264D+ 20
BLYP/6–31G 136.156 145.768 140.085 109.253 0.059 0.124 0.469D+ 20
BLYP/6–31G* 136.433 146.092 146.684 109.475 0.059 0.124 0.583D+ 20
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tal in the idealized Lewis structure, and their subsequent im-
pact on molecular stability and geometry (bond lengths) are
also related with the resulting p character of the corresponding
O29 natural hybrid orbital (NHO) of rC2–O110 bond orbital.3.1. Frequency calculations
The vibrational frequencies of methyldopa were calculated at
the, DFT (B3LYP, BLYP) and MP2 levels of theory using
the 3–21G*,6–31G,6–31G* basis set (Jensen James, 2005).
The entropies and heat capacities were calculated using statis-
tical mechanics based on the vibrational frequencies (Zheng
et al., 2005). The nature of all stationary point structuresPlease cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.orwas determined by analytical frequency analysis, which also
provide zero–point vibrational energies (ZPEs) (Cherkaoui
and Boutalib, 2006). Electronic energies, enthalpies, Gibbs free
energies and zero point vibrational energies for both the com-
pounds using frequency calculation at 298.15 K and 310.15 K
temperatures are presented in Tables 3-36–3-39. Thermo chem-
istry analysis follows the frequency and normal mode data.
Etot ¼ Et þ Er þ Ev þ Ee
Hcorr ¼ Etot þ kBT
Gcorr ¼ Hcorr Tstot
Stot ¼ St þ Sr þ Sv þ Seyldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
14 M. Noei et al.Sum of electronic and zero-point energies = DE+ EZPE
Sum of electronic and thermal energies = DE+ Etot
Sum of electronic and thermal enthalpies = DEþHcorr
Sum of electronic and thermal free energies = DEX± Gcorr
where DE is the total electronic energy at T= 0 K, Gcorr and
Hcorr which represents the thermal correction to Gibbs free
energy and enthalpy, respectively. The internal thermal energy
Etot is contributed from translational (Et), rotational (Er),
vibrational (Ev), and electronic (Ee) energies, and Stot, St, Sr,
Sv, Se are their corresponding entropies (An et al., 2005).
The next sections about the individual contribution to the
internal thermal energy (Etot), constant volume molar heat
capacity (Cv)tot, entropy (Stot) and Partition function (Q) Och-
terski, 2000. The partition functions are also computed, with
both bottom of the vibrational well and lowest (zero-point)
vibrational state as reference. The comparison of thermo
chemistry values was calculated for two structures, which
shows that with increasing temperature, these values increase
in both structures and also these values for methyldopa at
two temperatures are more than methyldopa which shows
the greater stability of methyldopa.
4. Conclusion
In this research we have calculated quantum calculations on
antihypertensive drugs such as Opt, NMR, NBO and IR and
the results of these calculations have been summarized in Ta-
bles 3-1–3-4. The main difference of methyldopa is in C8–
N15, C9‚O14 and C2–O11 bonds (Fig. 1) and the structural
details of these bonds have been reported in tables which are
based on our calculations. In fact these calculations are consid-
ered as a model and if a molecule has these properties which
have been mentioned in this paper and their data calculations
are similar to data calculations of this paper we can call it as a
new antihypertensive drug and in the next stage for more sur-
ety it is possible to test and synthesize it in the laboratory.
(1) we conclude from the calculations opt stable state with
the solvent ethanol is BLYP/3–21G* basis set.
(2) we conclude by the calculations that NMR riso for
atoms: C8–N15, C2–O11, C9‚O14 and Dr for atoms:
C2–O11, C9‚O14, and C8–N15 are related to the
solvent ethanol. (riso) for C8 = 136.2307,
N15 = 208.4537, C9 = 36.3880, O14 = 55.5087,
C2 = 67.0383, O11 = 215.1109 and Dr for
C8 = 282.386, N15 = 3413.925, C9 = 4971.069,
O14 = 56658.707, C2 = 2259.005, O11 = 7794.946).
(3) From the hybridation calculations of NBO, we conclude
the links to the following atoms C8–N15, C9 = O14,
and C2–O11 are related to the solvent ethanol.
(C8 = sp3.65,N15 = sp2.38, C9 = sp99.99,O14 = sp99.99,
C2 = sp3.12, O11 = sp2.41).
(4) The comparison of thermo chemistry parameters of
structures that are expressed in Tables 3-36–3-39 show
that with increasing temperature, the thermal correction
to Gibbs free energy and enthalpy (Gcorr, Hcorr), the
internal thermal energy (Etot), constant volume molar
heat capacity (Cv) tot, entropy (Stot) and the individualPlease cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.orcontributions to the internal thermal energy (Etot)
increase in structure and from these parameter values
for methyldopa we conclude that most frequencies of
IR calculations for atoms C9 = O14 = C8–
N15 = C2–O11 are related to the solvent ethanol fre-
quency calculations and we conclude that the links are
as follows: C8–N15:783.6411, C9‚O14:783.6411, C2–
O11:783.6411.Acknowledgements
We gratefully acknowledge the ﬁnancial support from the Re-
search Council of Islamic Azad University, Mahshahr Branch.References
Alexander, N., McClaskey, J., Maronde, R.F., 1976. Elevated plasma
dopaminebeta-hydroxylase activity in rats with neurogenic hyper-
tension. Life Sci. 18, 655–662.
Alexander, N., Velasquez, M., DeCuir, M., Maronde, P.F., 1980.
Indices ofsympathetic activity in the sinoaortic-denervated hyper-
tensive rat. Am. J. Physiol. 238, H521–H526.
Alexander, N., Nakahara, D., Ozaki, N., Kaneda, N., Sasaoka, T.,
IwataN, et al, 1988. Striatal dopamine release and metabolism in
sinoaorticdenervatedrats by in vivo microdialysis. Am. J. Physiol.,
254.
An, W., Gao, Y., Bulusu, S., Zeng, X.C., 2005. Ab initio calculation of
bowl, cage, and ring isomers of C20 and C20-. J. Chem. Phys. 122,
204109.
Benas, P., Bec, G., Keith, G., Mrquet, R., Ehresmann, C., Ehresmann,
B., Dumas, P., 2000. RNA* The crystal structure of HIV reverse-
transcription primer tRNA(Lys*3) shows acanonical anticodon
loop. J. RNA 6, 1347–1355.
Benveniste, H., Hu¨ttemeier, P.C., 1990. Micro dialysis––theory and
application. Prog. Neurobiol. 35, 195–215.
Chen, Z., Steger, R.W., 1993. Plasma micro dialysis. A technique for
continuous plasma sampling in freely moving rats. J. Pharmacol.
Toxicol. Methods 29, 111–118.
Cherkaoui, M., Boutalib, A., 2006. Ab initio investigation of thesub-
stituant effect of the alane complexes. Internet Electron. J. Mol.
Des. 5, 471–478.
Chocholousova, J., Vladimir Spirko, V., Hobza, P., 2004. Polar isomer
of formic acid dimes formed in helium nano droplets. Phys. Chem.
Chem. Phys. 6, 37.
Duncan, G.E., Paul, I.A., Fassberg, J.B., Powell, K.R., Stumpf, W.E.,
Breese, G.R., 1991. Autoradiographic analysis of the in vivo
distribution of3H-imipramine and 3H-desipramine in brain: com-
parison to in vitrobinding patterns. Pharmacol. Biochem. Behav.
38, 621–631.
Ellenbogen, A., Jaschevatzky, O., Davidson, A., Anderman, S.,
Grunstein, S., 1986. Management ofpregnancy-induced hyperten-
sion with pindolol––Comparative study with methyldopa. Int. J.
Gynaecol. Obstet. 24, 3–7.
Elmquist, W.F., Sawchuk, R.J., 1997. Application of microdialysis in
pharmacokineticstudies. Pharm. Res. 14, 267–288.
Fink, G.D., 1998. In: Brody, T.M., Larner, J., Minneman, K.P. (Eds.),
Human PharmacologyMolecular to Clinical. Mosby, St Louis, Mo.
Foster, J.P., Weinhold, F., 1980. Natural hybrid orbital’s. J. Am.
Chem. Soc. 102, 7211.
Garﬁnkel, H.A., 1972. Banana and L-dopa. Br. Med. J. 1, 312.
Giarcovich-Mart´ınez, S., Ferna´ndez, M., Chemerinski, E., Enero,
M.A., 1983. Central serotonergic activity after neurogenic hyper-
tension. Eur. J. Pharmacol. 86, 337–345.yldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
Design of methyldopa structure and calculation of its properties by quantum mechanics 15Jensen James, O., 2005. Quantum chemical analysis of the vibration-
alfrequencies and structure of tetrachlorodiborane. J. Mol. Struct.
(Theochem) 635, 211–219.
Ledoux, J.E., Sakaguchi, A., Reis, D.J., 1983. Alpha-methylDOPA
dissociateshypertension, cardiovascular reactivity and emotional
behavior inspontaneously hypertensive rats. Brain Res. 259, 69–76.
Lynden Bell, R.M., Rasaiah, J.C., 1997. From hydrophobic to
hydrophilic behavior: simulation study of salvation entropy and
free energy of simple solutes. J. Chem. Phys. 107, 1981–1991.
Magdalena, P., Sadlej, J., 1998. Solvent effects on NMR spectrum of
acetylene calculated by ab intio methods. Chem. Phys. 234, 111–
119.
Melinda, A.J.D., 2003. Solid State NMR Spectroscopy. Principles and
Applications. Cambridge press (321,112–118).
Mizuchi, A., Kitagawa, N., Miyachi, Y., 1983. Regional distribution
of sultoprideand sulpiride in rat brain measured by radioimmuno-
assay. Psychopharmacology (Berl) 81, 195–198.
Mollaamin, F., Noei, M., Monajjemi, M., Rasoolzadeh, R., 2011.
Nano theoretical studies of fMet-tRNA structure in protein
synthesis of prokaryotes and its comparison with the structure of
fAla-tRNA. Afr. J. Microbiol. Res. 5, 2667–2674.
Monajjemi, M., Noei, M., Mollaamin, F., 2010. Design of fMet-tRNA
and calculation of its bonding properties by quantum mechanics.
Nucleosides, Nucleotides and Nucleic Acids 299, 676–683.
Monajjemi, M., Heshmat, M., Aghaei, H., Ahmadi, R., Zare, K.,
2007. Solvent effects on 14N NMR shielding of glycine, serine,
leucineg and threonine: comparison between chemical shift and
energy versus dielectric constant. Bull. Chem. Soc. Ethiop. 21, 111–
116.
Nakamura, K., Nakamura, K., 1981. Inﬂuence of sino-aortic barore-
ceptordenervation on catecholamines, catecholamine-synthesizing
enzymesand choline acetyltransferase activity in the brainstem
nuclei of therat. Jpn. J. Pharmacol. 31, 95–105.
Noei, M., Suzangarzadeh, S., Golshani, S., Tahan, A., 2011. The Ab
initio study and nbo analysis of the solvent dielectric constant
effects and the implicit water moleculesb on the structural stability
of the 1_(6_chloroquinoxalin_2_yl)_2_(4_(triﬂuoro-
methyl)_2,6_dinitrophenyl) hydrazine1. Russ. J. Phys. Chem. A
85 (6), 993–1000.
Noei, M., Salari, A.A., Baei, Mohammad T., Hajizadeh, F., Jamal
Kazemi Asl, Mohammad Ramezani Taghartapeh, 2011. Theoret-
ical study of fMet-tRNA and fAla-tRNA structures by using
quantum calculation. Arab. J. Chem. 20, 23–35.
Ochterski, J.W., 2000. Ph.D., Thermochemistry in Gaussian; June 2.
Pavlov, M.Y., Antoun, A., Lovmar, M., Ehrenberg, M., 2008.
Complementary roles of initiation factor 1and ribosome recycling-
factor in 70S ribosome splitting. EMBO J. 27, 1706–1717.
Oparil, S., 1982. Review of therapeutic modalities acting directly via
central pathways. Clin. Exp. Hypertens. A Theory Pract. 4, 579–
593.Please cite this article in press as: Noei, M. et al., Design of meth
mechanics. Arabian Journal of Chemistry (2013), http://dx.doi.orOpezzo, J.A.W., Ho¨cht, C., Bramuglia, G.F., Taira, C.A., 2000. Study
of theevolution of blood and striatal levels of methyldopa: a
microdialysisstudy in sinoaortic-denervated rats. Pharmacol. Res.
41, 455–459.
Reed, A.E., Weinhold, F., 1983. Natural bond orbital analysis of near-
hartree-fock water dimer. J. Chem. Phys. 78, 4066.
Reed, A.E., Weinhold, F., 1985. Some remarks on the C-H bond
dipole moment. J. Chem. Phys. 83, 1736.
Reed, A.E., Weinstock, R.B., Weinhold, F., 1985. J. Chem. Phys. 83,
735.
Robertson, D., Tung, C.H., Goldberg, M.R., Hollister, A.S., Gerkens,
J.F., Oates, J.A., 1984. Antihypertensive metabolites of-methyl-
dopa. Hypertension 6 (Suppl. II), 5–7, II45–50.
Sojo, M.M., Nuhez-Delicado, E., Garcı´a-Carmona, F., Sa´nchez-
Ferrer, A., 1999. Cyclodextrins as activator and inhibitor of latent
banana pulp polyphenol oxidase. J. Agric. Food Chem. 47, 518–
523.
Sojo, M.M., Nuhez-Delicado, E., Sa´nchez-Ferrer, A., Garcı´a-Car-
mona, F., 2000. Oxidation of salsolinolby banana pulp polyphenol
oxidase and its kinetic synergism with dopamine. J. Agric. Food
Chem. 48, 5543–5547.
Taira, C.A., Enero, M.A., 1989. Interaction between clonidine and
physostigminein normal rats and in rats after sinoaortic
denervation. Naunyn. Schmiedebergs Arch. Pharmacol. 339,
522–527.
Taira, C.A., Celuch, S.M., Enero, M.A., 1983. Effects of acute and
short-termtreatment with antihypertensive drugs in sinoaortic-
denervated rats. Gen. Pharmacol. 14, 657–661.
Nippon Universal Pharmaceutical Co, 2008. Aldomet Tablets-125/250.
Ethical Drug Package Insert 4, 1–27.
van Zwieten, P.A., Thoolen, M.J.M., Timmermans, P.B.W.M., 1984.
The hypotensiveactivity and side effects of methyldopa. Hyperten-
sion 6 (Suppl. II), II28–II33.
Witanowski, M., Sicinska, W., Grabowski, Z., Webb, G.A., 1990.
Solvent effects on nitrogen shielding of 1,2,4-triazin. Mag. Res.
Chem 28, 988.
Witanowski, M., Sicinska, W., Biernat, S., Webbg, A.J., 1991. Solvent
effects on nitrogen NMR shielding in azine. Magn. J. Magn. Res
91, 289.
Yang, C.P., Fujita, S., Ashrafuzzaman, M., Nakamura, N., Hayashi,
N., 2000. Puriﬁcation and characterization of polyphenol oxidase
from banana (Musa sapientum L.) pulp. J. Agric. Food Chem. 48,
2732–2735.
Zheng, X.L., Sun, H.Y., Law, C.K., 2005. Thermochemical and
kineticanalysis on oxidation of isobutenyl radical and 2-hydro-
peroxymethyl-2-propenyl radical. J. Phys. Chem. A 109, 9044–
9053.yldopa structure and calculation of its properties by quantum
g/10.1016/j.arabjc.2013.07.021
